Serum C-reactive protein to albumin ratio as a novel inflammation biomarker in psoriasis patients treated with adalimumab, ustekinumab, infliximab, and secukinumab: a retrospective study.

Autor: Tamer, Funda1 fundatmr@yahoo.com, Avcı, Emine1
Zdroj: Croatian Medical Journal. Aug2020, Vol. 61 Issue 4, p333-337. 5p.
Databáze: Academic Search Ultimate